Robinson R, et al. - Authors ascertained if certain foot/ankle surgeries would benefit from the routine use of low-molecular-weight heparin (LMWH) as postoperative deep venous thrombosis prophylaxis. They found an association of prophylaxis with both worse health outcomes and greater costs, for hallux valgus surgery (HVS). Worse health outcomes were seen in association with routine prophylaxis which either incoured more cost (hindfoot arthrodesis (HA), ankle fracture surgery (AFS), hallux valgus surgery (HVS)) or saved very little (achilles tendon repair (ATR), total ankle arthroplasty (TAA)) when applied for long term. Experts noted the unlikeliness of policies encouraging the routine use of LMWH after foot/ankle surgery to be cost-effective. The decisions to perform prophylaxis ought to be on a case-by-case basis and should emphasize individual patient risk factors.